Register now to our Newsletter

* indicates required

Our latest news

Science VS Sars-Cov-2: science could win

We from TCS are leveraging our human immune system models and knowledge to assist our customer in the fight against SARS-Cov2

New Disease Model: human hepatocytes (hu-liver) Mouse Models

Find out the details on how TransCure bioServices will improve human liver diseases research and development with its novel and innovative human hepatocytes (hu-liver) mouse models.

Brand New Rodent Animal Facility at TransCure bioServices

We have remodeled, expended, and totally refurbished our current animal facility to a state-of-the-art mouse facility of 500 m2 (5'300 ft2)

Webinar 2021 Sessions in Immuno-Oncology, IBD and Infectious Diseases

Webinar 2020 Sessions, hosted by Sebastien Tabruyn, PhD, CSO will be reconducted in 2021. Stay tuned.

TransCure bioServices Latest Arrivals

We welcome our new scientific writer and project manager. Take a moment to know them.

Our animal and lab facilities are evolving

Our animal facility is evolving relying on a 4500+ mouse capacity and cutting-edge humanized models and running more than 500 humanizations per month.

New employees have arrived at TransCure bioServices

We welcome our new scientific writer and project manager. Take a moment to know them.

TransCure bioServices fully operational despite the current challenges

Our team is -giving the current circumstances- still working on full speed for our international customers and we´ve implemented the strictest rules to reduce the impact of SARS-COV-2 on our company employees and management.
Estelle Soares, Coralie Dannet

Last hired at TransCure bioServices

TransCure bioServices is growing.
Fastest-Growing companies

TCS 666th of Europe’s fastest-growing companies

TransCure bioServices ranked 666 in the TOP 1000 Europe fastest-growing companies!

Share this!